| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:2116.)
© 2005 American Heart Association, Inc.
Original Contributions |
From the Alzheimer Center (W.M.v.d.F., E.C.W.v.S., F.B., P.S.) and the Departments of Neurology (W.M.v.d.F., E.C.W.v.S., P.S.) and Radiology (F.B.), and the Image Analysis Centre (IAC) (E.C.W.v.S., F.B.), Vrije Universiteit Medical Center, Amsterdam, The Netherlands; the Serviço de Neurologia (A.V., S.M.), Centro de Estudos Egas Moniz, Hospital de Santa Maria, Lisboa, Portugal; the Department of Neurological and Psychiatric Sciences (L.P., D.I.), University of Florence, Florence, Italy; the Memory Research Unit, Department of Clinical Neurosciences (T.E.), Helsinki University, Helsinki, Finland; the Neurotec Department, Section of Clinical Geriatrics (M.C.), Karolinska Universitetssjukhuset, Huddinge University Hospital, Huddinge, Sweden; the Memory Disorders Research Unit, Department of Neurology (F.W.), Copenhagen University Hospital, Copenhagen, Denmark; and the Department of Neurology and MRI Institute (R.S., F.F.), Medical University, Graz, Austria.
Correspondence to W. M. van der Flier, PhD, Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands. E-mail wm.vdflier{at}vumc.nl
| Abstract |
|---|
|
|
|---|
Methods Data were drawn from the multicenter, multinational Leukokraurosis and Disability (LADIS) study. There were 633 independently living participants. General cognitive function was assessed using the Mini Mental State Examination (MMSE) and the modified Alzheimer Disease Assessment Scale (ADAS). On MRI, WMH was rated as mild, moderate, or severe. Lacunes were rated as none, few (1 to 3), or many (4 or more).
Results In the basic analysis, increasing severity of both WMH and lacunes was related to deteriorating score on the MMSE and ADAS. When WMH and lacunes were entered simultaneously, both MRI measures remained significantly associated with MMSE score. Increasing severity of WMH remained associated with ADAS score, whereas the association with lacunes became less prominent. These associations were independent of other risk factors for dementia, like education, depression, vascular risk factors, or stroke.
Conclusion We found WMH and lacunes to be independently associated with general cognitive function in a sample of independently living elderly. These results highlight the fact that WMH and lacunes should both be evaluated when assessing small vessel disease in relation to cognitive function.
Key Words: cognition elderly lacunes small vessel disease white matter hyperintensities
| Introduction |
|---|
|
|
|---|
There is increasing attention for the importance of small vessel disease as a predictor of cognitive decline and dementia. Small vessel disease is implicated in vascular dementia.11,12 Moreover, it seems to amplify the effects of pathologic changes of Alzheimer disease.1315 Subtle associations between WMH and cognitive impairment have been reported in nondemented elderly.5,16,17 The cognitive correlates of lacunes have received less attention. Results are conflicting, because some authors report associations with cognitive impairment, whereas others do not.9,18,19 In addition, the relative impact of WMH and lacunes on cognitive impairment is not known.
In the present study, we investigated the independent contribution of WMH and lacunes to general cognitive function in a group of independently living elderly with varying degrees of small vessel disease.
| Materials and Methods |
|---|
|
|
|---|
All subjects were assessed using clinical and functional tests, including global functioning, cognitive, motor, psychiatric, and quality-of-life measures. For the present study, general cognitive function was measured using the Mini Mental State Examination (MMSE)23 and a modified version of the Alzheimer Disease Assessment Scale (ADAS).24 The ADAS was slightly modified to include the item "delayed word recall." A higher MMSE score indicates better performance, whereas a higher ADAS score corresponds to worse performance. ADAS score was missing in 6 subjects, so 633 subjects had available data for the present study. The following variables were evaluated as confounders: age, sex, education (years), depressive symptoms,25 motor function,26,27 hypertension, diabetes, smoking, and history of stroke.
All subjects were studied by MRI following a standard protocol on the same day as the clinical investigation. Scans were made on a 0.5-T (one center) or 1.5-T scanner (10 centers) and were collected centrally at the Image Analysis Centre (IAC) of the Vrije Universiteit Medical Center, Amsterdam. Imaging guidelines were distributed among all centers, specifying naming convention and scan positioning. To check and maintain quality, dummy runs were requested before the beginning of the study and in case of upgrades. Data transfer was electronic through FTP. The MR protocol included the following sequences: T1-weighted 3D MPRAGE (magnetization prepared rapid-acquisition gradient-echo, scan parameters: coronal or sagittal plane, field of view [FOV] 250 mm, matrix 256x256 or 512x512, slice thickness: 1 mm [isotropic voxels], TE: 2 to 7 ms, TR: 9 to 26 ms, FA 10% to 30%), T2-weighted FSE (fast spin echo, scan parameters: axial plane, FOV 250 mm, matrix 256x256 or 512x512, slice thickness: 5 mm, interslice gap 0.5 mm, TE: 100 to 130 ms, TR: 4000 to 8000 ms), and FLAIR (fluid-attenuated inversion recovery, scan parameters: axial plane, FOV 250 mm, matrix 256x256 or 512x512, slice thickness: 5 mm, interslice gap 0.5 mm, TE: 100 to 160 ms, TR: 6000 to 10000 ms, TI: 2000 to 2400). Visual ratings of WMH and counts of lacunes were performed centrally by a single rater (ECWvS) who was blind to clinical details. The degree of WMH severity was rated visually on axial FLAIR images using the Fazekas scale as grade 1 (punctate), grade 2 (early confluent), or grade 3 (confluent).21 Lacunes were defined as hypointense foci of
3 mm on MPRAGE that were surrounded by white matter or subcortical gray matter and not located in areas with a high prevalence of widened perivascular spaces (eg, anterior commissure, vertex).28 The number of lacunes was recoded into none, few (1 to 3 lacunes), and many (4 lacunes or more). The intrarater reliability of rating of WMH was determined on 18 randomly selected scans that were scored twice (weighted Cohen
=0.84). Interrater reliabilities and intrarater reliability of lacunes were not determined.
Statistical analysis was performed using SPSS for windows (release 11.5). Spearmans correlation was used to assess the association between WMH and lacunes. The strength of the associations between small vessel disease and cognitive measures was assessed using partial correlations, correcting for age and sex. Associations between small vessel disease and general cognitive function were assessed using general linear models for MMSE and ADAS separately. WMH and lacunes were entered as continuous variables. Age and sex were entered as covariates in all models. First, basic associations between general cognitive function and WMH and between general cognitive function and lacunes were assessed. Subsequently, WMH and lacunes were entered simultaneously to assess their independent contribution to cognitive function. The interaction between WMH and lacunes was tested. Because 11 different centers participate in the LADIS project, it is conceivable that center of origin acts as a confounder in the association between small vessel disease and cognition. Therefore, center of origin was entered as a factor in the GLM. Additional corrections were made for education, depressive symptoms, motor function, hypertension, diabetes, smoking, and a history of stroke.
| Results |
|---|
|
|
|---|
|
|
General linear models were performed for WMH and lacunes separately, correcting for age and sex and with the MMSE and the ADAS as dependent variable. In these basic models, WMH and lacunes each were associated with score on the MMSE and ADAS (MMSE-WMH: ß[se]=0.48 [0.12], P<0.001; MMSE-lacunes: ß[se]=0.62 [0.14]), P<0.001, ADAS-WMH: ß[se]=1.31 [0.35], P<0.001; ADAS-lacunes: ß[se]=1.12 [0.41], P=0.007, Figure 2). Partial correlations corrected for age and sex were 0.16 and 0.18 (both P<0.001) for MMSE with WMH and lacunes, respectively, and 0.15 (P<0.001) and 0.11 (P=0.007) for ADAS with WMH and lacunes.
|
To assess the independent effect of WMH and lacunes on general cognitive function, both variables were entered simultaneously into general linear models (Table 2). Increasing WMH and lacunes were independently associated with a lower score on the MMSE. With increasing severity of WMH, the performance on the ADAS deteriorated. In the multivariate model, increasing severity of lacunes tended to be associated with worse performance on the ADAS, but this association was less prominent. There was no interaction between lacunes and WMH. The interaction term was therefore left out of subsequent analyses. Correction for possible confounders left results largely unaltered. Results did not change after exclusion of subjects with an infarct other than a lacune on MRI.
|
| Discussion |
|---|
|
|
|---|
Small vessel disease is prevalent among the elderly.29,30 Several population-based studies have shown before that, small vessel disease may cause subtle cognitive deficits in nondemented subjects.5,9,16,17 In the present study, we demonstrated that both WMH and lacunes independently influence cognitive function. We found only a moderate correlation between WMH and lacunes, supporting the view that they are 2 distinct expressions of small vessel disease. Lacunar infarcts are produced when the ischemic damage is focal and of sufficient severity to result in a small area of necrosis.12 They are largely confined to the cerebral white matter and subcortical structures, including the basal ganglia, thalamus, and brain stem. In contrast, diffuse WMH, considered to be a form of rarefaction or incomplete infarction, are usually widespread.
In the present study, we defined small vessel disease as WMH and lacunes on MRI. Although these MRI abnormalities are generally considered as measures of small vessel disease, they have in fact variable pathologic correlates.13,31 Arteriolosclerosis has been reported to be the primary factor in the pathogenesis of WMH in the elderly. Alternatively, WMH may have as diverse pathologic correlates as loss of myelin, axons, and oligodendroglial cells, dilatation of perivascular spaces, and mild reactive astrocytic gliosis.
There have been a few studies evaluating the simultaneous effect of WMH and lacunes in a sample of subjects with a broad range of cognitive impairment.19,32,33 In these studies, WMH were found to be related to cognitive impairment, but there were no independent associations between lacunes and cognitive dysfunction. In addition, there has been a large population-based study assessing risk factors and functional consequence of lacunes that showed associations between lacunes and cognitive function, even after correction for WMH.9 In the present study, we demonstrated both lacunes and WMH to be associated with general cognitive function as measured using the MMSE. Scores on the ADAS were related to WMH and lacunes in the basic analysis. However, the association between ADAS score and lacunes was not independent of WMH, although associations remained borderline significant. Insufficient power may be partly responsible for the disappearance of the significant association, because the variability in ADAS is larger than the variability in MMSE. Furthermore, ADAS and MMSE are both widely used tests of general cognitive function. The fact that even with these relatively crude measures, clear associations with small vessel disease were observed, underlines the clinical relevance of both WMH and lacunes. However, it is conceivable that tests of cognitive functions specifically associated with small vessel disease such as mental speed and executive function may yield even stronger associations with WMH and lacunes.
Among the strengths of the present study is the large sample size. Each subject underwent MRI scanning. All scans were analyzed centrally, which guaranteed reliability of MRI measures. Patients were selected to represent a broad range of WMH, enabling us to assess the subtle associations of small vessel disease and cognitive function. Among the limitations of the study may be the subject selection. Subjects were identified mainly in a hospital or secondary/tertiary referral setting. The study sample was selected to represent the full range of severity of WMH. Although stratification by WMH may hamper the generalizability of the results to the general population, the reasons for referral were those commonly leading to discover WMH in elderly persons, so that the LADIS sample likely reflects the assorted patient population with WMH encountered in everyday clinical practice. Because subjects were selected to be nondisabled, we were not able to evaluate the full spectrum of cognitive impairment. Subjects were allowed to have minor problems such as mild memory loss or minor motor disturbances. However, because subjects were required to be nondisabled, subjects with fullfledged dementia were not eligible. Consequently, we may even have underestimated the strength of the associations between small vessel disease and cognitive function. Another limitation is the fact that we did not include a measure of cerebral gray matter volume. Therefore, it is conceivable that the reported associations are the result of global or regional atrophy rather than ischemic changes. The cross-sectional setting of the present study prevents inferences on the causality of the reported associations. Further research is currently being performed to determine the contribution of small vessel disease to cognitive decline over time.
In conclusion, we found WMH and lacunes to be independently associated with cognitive function in a sample of independently living elderly. These results provide further evidence for the importance of small vessel disease in cognitive impairment at old age, and they highlight the fact that WMH and lacunes should both be evaluated when assessing small vessel disease in relation to cognitive function.
| Appendix |
|---|
|
|
|---|
The LADIS Steering Committee is formed by Domenico Inzitari, MD (study coordinator), Timo Erkinjuntti, MD, PhD, Philip Scheltens, MD, PhD, Marieke Visser, MD, PhD, and Kjell Asplund, MD, PhD.
| Acknowledgments |
|---|
Received May 3, 2005; revision received May 18, 2005; accepted May 30, 2005.
| References |
|---|
|
|
|---|
Related Articles:
This article has been cited by other articles:
![]() |
S. Bombois, S. Debette, A. Bruandet, X. Delbeuck, C. Delmaire, D. Leys, and F. Pasquier Vascular Subcortical Hyperintensities Predict Conversion to Vascular and Mixed Dementia in MCI Patients Stroke, July 1, 2008; 39(7): 2046 - 2051. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ikram, M. van Oijen, F. J. de Jong, J. A. Kors, P. J. Koudstaal, A. Hofman, J. C.M. Witteman, and M. M.B. Breteler Unrecognized Myocardial Infarction in Relation to Risk of Dementia and Cerebral Small Vessel Disease Stroke, May 1, 2008; 39(5): 1421 - 1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pantoni Leukoaraiosis: From an Ancient Term to an Actual Marker of Poor Prognosis Stroke, May 1, 2008; 39(5): 1401 - 1403. [Full Text] [PDF] |
||||
![]() |
G. F. OXENKRUG Genetic and Hormonal Regulation of Tryptophan Kynurenine Metabolism: Implications for Vascular Cognitive Impairment, Major Depressive Disorder, and Aging Ann. N.Y. Acad. Sci., December 1, 2007; 1122(1): 35 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Verdelho, S. Madureira, J. M Ferro, A.-M. Basile, H. Chabriat, T. Erkinjuntti, F. Fazekas, M. Hennerici, J. O'Brien, L. Pantoni, et al. Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study J. Neurol. Neurosurg. Psychiatry, December 1, 2007; 78(12): 1325 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
L BRONGE and L-O WAHLUND White matter changes in dementia: does radiology matter? Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S115 - S120. [Abstract] [Full Text] [PDF] |
||||
![]() |
S MILLS, J CAIN, N PURANDARE, and A JACKSON Biomarkers of cerebrovascular disease in dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S128 - S145. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gold, P. Giannakopoulos, F. R Herrmann, C. Bouras, and E. Kovari Identification of Alzheimer and vascular lesion thresholds for mixed dementia Brain, November 1, 2007; 130(11): 2830 - 2836. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Bowler Modern concept of vascular cognitive impairment Br. Med. Bull., September 1, 2007; 83(1): 291 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schmidt, K. Petrovic, S. Ropele, C. Enzinger, and F. Fazekas Progression of Leukoaraiosis and Cognition Stroke, September 1, 2007; 38(9): 2619 - 2625. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Kalaria Rounding up the usual suspects: Lacunar infarction and impairment in CADASIL Neurology, July 10, 2007; 69(2): 131 - 132. [Full Text] [PDF] |
||||
![]() |
L. A. van de Pol, E. S. C. Korf, W. M. van der Flier, H. R. Brashear, N. C. Fox, F. Barkhof, and P. Scheltens Magnetic Resonance Imaging Predictors of Cognition in Mild Cognitive Impairment Arch Neurol, July 1, 2007; 64(7): 1023 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jokinen, C. Ryberg, H. Kalska, R. Ylikoski, E. Rostrup, M. B Stegmann, G. Waldemar, S. Madureira, J. M Ferro, E. C W van Straaten, et al. Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: the LADIS Study J. Neurol. Neurosurg. Psychiatry, May 1, 2007; 78(5): 491 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Freeman, C. J. Collura-Burke, N. J. Patronas, L. S. Ilcus, D. Darnell, J. Davis, J. M. Puck, and S. M. Holland Brain Abnormalities in Patients With Hyperimmunoglobulin E Syndrome Pediatrics, May 1, 2007; 119(5): e1121 - e1125. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lin, L. Svensson, R. Gupta, B. Lytle, and D. Krieger Chronic ischemic cerebral white matter disease is a risk factor for nonfocal neurologic injury after total aortic arch replacement J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1059 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M VAN DER FLIER, F. BARKHOF, and P. SCHELTENS Shifting Paradigms in Dementia: Toward Stratification of Diagnosis and Treatment Using MRI Ann. N.Y. Acad. Sci., February 1, 2007; 1097(1): 215 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Drachman Aging of the brain, entropy, and Alzheimer disease Neurology, October 24, 2006; 67(8): 1340 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Munoz Leukoaraiosis and Ischemia: Beyond the Myth Stroke, June 1, 2006; 37(6): 1348 - 1349. [Full Text] [PDF] |
||||
![]() |
W.T. Longstreth Jr Brain Vascular Disease Overt and Covert Stroke, October 1, 2005; 36(10): 2062 - 2063. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||